Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Anemia
Related studies linked through entity extraction aliases.
A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in India
- Status
- COMPLETED
- Phase
- NA
A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.
- Status
- COMPLETED
- Phase
- PHASE2
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia
- Status
- COMPLETED
- Phase
- N/A
A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children
- Status
- COMPLETED
- Phase
- N/A
A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies
- Status
- WITHDRAWN
- Phase
- N/A
An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.
- Status
- COMPLETED
- Phase
- PHASE2
Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.
- Status
- COMPLETED
- Phase
- PHASE2
The Duration Study
- Status
- TERMINATED
- Phase
- PHASE3
Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
- Status
- TERMINATED
- Phase
- PHASE2
Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation
- Status
- COMPLETED
- Phase
- PHASE3
Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of Anemia
- Status
- COMPLETED
- Phase
- NA
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced
- Status
- TERMINATED
- Phase
- PHASE2